Literature DB >> 1557232

Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka.

C Mendis1, G Del Giudice, A C Gamage-Mendis, C Tougne, A Pessi, S Weerasinghe, R Carter, K N Mendis.   

Abstract

Antibodies to two peptides DDAAD and (NANP)40 representing the repetitive sequence of circumsporozoite antigens (CS protein) of P. vivax and P. falciparum respectively were measured in a cohort of 149 and 107 individuals respectively at four, 6 monthly blood surveys performed on residents of Kataragama, a P. vivax malaria endemic region in southern Sri Lanka. The prevalence of antibodies to the CS protein of both species was relatively low being less than 20% to either peptide in the population as a whole, this being consistent with the low entomological inoculation rates in the area. A marked age related prevalence pattern was evident, with the prevalence of antibodies increasing with age to reach between 25 to 30% in the 25-50 year age group in both P. vivax and P. falciparum. The population had had a life long exposure to P. vivax malaria but not to P. falciparum, an epidemic of which occurred in this region a few months prior to the beginning of this study. Nevertheless, the age-related prevalence of these antibodies was identical with respect to the two species. This suggests that the age-related prevalence pattern reflected differences in inoculation rates between the age groups due to differences in exposure to inoculation rather than an age acquired response resulting from a cumulative experience over several years. An analysis of antibody prevalence in individuals showed first, that sporozoite inoculations must have been clustered rather than homogeneously distributed in the population and secondly, that sero-conversion did not correlate with malaria infections in these individuals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557232     DOI: 10.1111/j.1365-3024.1992.tb00007.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  4 in total

1.  IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk.

Authors:  Will Stone; Teun Bousema; Sophie Jones; Samwel Gesase; Rhamadhan Hashim; Roly Gosling; Ilona Carneiro; Daniel Chandramohan; Thor Theander; Raffaele Ronca; David Modiano; Bruno Arcà; Chris Drakeley
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 2.  Research priorities for the development and implementation of serological tools for malaria surveillance.

Authors:  Salenna R Elliott; Freya J I Fowkes; Jack S Richards; Linda Reiling; Damien R Drew; James G Beeson
Journal:  F1000Prime Rep       Date:  2014-11-04

3.  Post-exposure serological responses to malaria parasites in potential blood donors.

Authors:  Daniela Portugal-Calisto; Ana Raquel Ferreira; Marcelo Sousa Silva; Rosa Teodósio
Journal:  Malar J       Date:  2016-11-09       Impact factor: 2.979

4.  Prevalence and Level of Antibodies Anti-Plasmodium spp. in Travellers with Clinical History of Imported Malaria.

Authors:  Rita Medina Costa; Karina Pires de Sousa; Jorge Atouguia; Luis Távora Tavira; Marcelo Sousa Silva
Journal:  J Parasitol Res       Date:  2013-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.